Short Seller Andrew Left Goes Sour On Lemonade, Says Company Lies To Shareholders
January 16, 2021 at 12:22 PM EST
Citron Research’s Andrew Left criticized insurance company Lemonade Inc. on Friday, saying its stock multiple is based on empty marketing tactics.
